We Know IBD - Current Trials

Current

Trials

By participating in a clinical trial, you may play a role in bringing us closer to finding treatment options that work for everyone affected.

Janssen is currently conducting the following clinical trials for people with IBD:

CROHN'S DISEASE

Logo Duet CD

The DUET-CD Study is evaluating the safety and efficacy of a combination of two investigational medications compared with placebo in adults with moderately to severely active Crohn's disease.

Logo Graviti

The GRAVITI Study is evaluating the safety and efficacy of an investigational medication compared with placebo in adults with moderately to severely active Crohn's disease.

ULCERATIVE COLITIS

Logo Astro

The ASTRO Study is evaluating the safety and efficacy of an investigational medication compared with placebo in adults with moderately to severely active ulcerative colitis.

Logo Duet UC

The DUET-UC Study is evaluating the safety and efficacy of a combination of two investigational medications compared with placebo in adults with moderately to severely active ulcerative colitis.

New clinical trials will be added to this page as they become available, so check here frequently for updates.

This website includes information about clinical trials in the United States. To see a list of participating countries, please:

Visit This Page

TRIAL LOCATIONS

The map below shows the locations where we currently have trial clinics supporting our IBD clinical trials.

Don't see one in your area? You can still answer a brief questionnaire here to see if you may qualify and save your information. That way we can reach out to you as new trial clinics open up in your area.

New trials and locations will be added as they become available-you can use this page to check for updates.

PARTICIPATING
COUNTRIES

The countries currently participating in the IBD clinical trials are listed below. For more information, please visit ClinicalTrials.gov.

Participating Country

Argentina

Australia

Austria

Belgium

Bosnia and Herzegovina

Brazil

Bulgaria

Canada

Chile

China

Croatia

Czech Republic

Denmark

Estonia

Finland

France

Georgia

Germany

Greece

Hungary

India

Israel

Italy

Japan

Jordan

Latvia

Lithuania

Malaysia

Mexico

Netherlands

New Zeland

Norway

Poland

Portugal

Serbia

Slovakia

Slovenia

South Korea

Spain

Sweden

Switzerland

Taiwan

Turkey

United Kingdom

United States